Liz is Senior Product Manager at Qkine, a Cambridge-based manufacturer of high-quality bioactive growth factors and cytokines for cell therapy, regenerative medicine and stem cell and organoid research. She holds a PhD from the University of Nottingham and has over a decade of translational research experience in neovascular eye diseases, including eight years of postdoctoral work on primary cell–based ex vivo models of disease progression. As Principal Scientist at Exonate, she led R&D on small molecules for splicing control in neovascular disease, cancer, and inflammation, advancing drug candidates into Phase I/II clinical trials.

At Qkine, Liz combines her commercial and scientific expertise to lead product strategy on their range of animal-free recombinant proteins and cell culture supplements while building and fostering collaborations with cell therapy manufacturers, biotech and academia.